Capable Launches AI Lab for 24-Hour Drug Design to Data Pipeline

The company says its new lab can turn AI-led drug designs into experimental data within a day, starting with short-sleeper peptides.

RO#44

In a post on X, Capable's Isaak Freeman said the company has built a lab that can go from "AI-led drug design to data in 24h," calling it a needed "biological compute layer" and saying the work will start with short-sleeper peptides. The claim spread through endorsements from Peter Diamandis, who called Capable a "generational company," and a repost from Jason Crawford. So far, the public evidence is the company's own announcement and the X posts amplifying it.

CAPABLE is a generational company. They are Genius-Level-Brilliant and the most mission-driven founders I've seen. Solving the translation from "AI into drugs" to advance humanity in the age of AI.

PDPeter DiamandisTECH#1776via X

Commentary on X

Highest ranked

navya b.@navyadotbioTECH

@isaakfreeman this is exactly the wedge that needs to be tackled to solve therapeutics once and for all. bravo for taking it head on and I am incredibly excited to see where this goes

Capable Launches AI Lab for 24-Hour Drug Design to Data Pipeline

Commentary on X

Combined views

Sentiment

Positive Read

Negative Read

Useful Links

Digg Deeper